<DOC>
	<DOC>NCT01471275</DOC>
	<brief_summary>With metformin for the control, evaluate the safety and efficacy of Jiangtangtiaozhi decoction in treatment of obesity with type 2 diabetes, dyslipidemia</brief_summary>
	<brief_title>Chinese Medicine Treatment of Obesity With Type 2 Diabetes, Dyslipidemia</brief_title>
	<detailed_description>Waist circumference, body mass index, triglycerides, glycosylated hemoglobin, blood glucose were evaluated; liver function, kidney function, blood, urine, stool, adverse event recording, evaluation of low blood sugar event log security.</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1. signed informed consent; 2. waistline male ≥ 90cm, female ≥ 80cm; 3. According to the 1999 WHO standards, meet diagnostic criteria for type 2 diabetes onset and untreated patients, after a screening period (diet + exercise therapy 4 weeks) after the fasting plasma glucose ≥ 7.0mmol • L1, but fasting blood glucose &lt;13.9mmol • L1, or 2h postprandial blood glucose ≥ 11.1mmol • L1; and glycated hemoglobin ≥ 7.0%; 4. After a screening period (diet + exercise therapy 4 weeks) after the triglyceride (TG) ≥ 1.7mmol / L, and TG &lt;5.65mmol / L; 5. TCM for the heat of the gastrointestinal; 6. Age 3065 years old. 1. Patients has been used insulin therapy; previously had a continuous period of 3 months or longer treatment of diabetes(including other Chinese and Western medicine, physical therapy, psychological therapy and health food, etc.) ; enrolled within 1 month before the use of blood glucose and lipids drug treatment; 2. Patients with diabetic complications; or a serious heart, lung, liver, kidney, brain and other serious complications or associated with other primary diseases; 3. Patients with uncontrolled blood pressure control, the systolic blood pressure ≥ 160mmHg or (and) diastolic blood pressure ≥ 100mmHg persons; 4. Patients have diabetic ketoacidosis in the last month, diabetic ketoacidosis and severe infections; 5. Patients with mental illness; 6. Pregnancy, pregnancy or breastfeeding women to prepare; 7. Patients with Chinese medicine allergies; and allergy; 8. Patients with had participated in this study within 1 month have participated or are participating in other clinical studies; 9. In the past five years, patients with alcohol and / or psychoactive substances, drug abuse and dependence; 10. According to the researchers to determine, with the possibility of lower income group or the other into a complex set of diseases or conditions, such as work environment, frequent changes in unstable living environment, the situation could easily lead to lost; 11. Patients taking the dose and type of antihypertensive drugs can not remain stable; 12. Patients taking drugs that affect the quality of the body or health food. 13. Patients with liver, impaired renal function (ALT, AST greater than 2 times the upper limit of normal; serum creatinine greater than the upper limit of normal); 14. Patients are known to lower blood sugar for those who are asymptomatic.</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>obesity</keyword>
	<keyword>hypertriglyceridemia</keyword>
</DOC>